Physician profile

Justin Roberts

Gerontology (Nurse Practitioner) · Muskogee, OK

NPI 1962953158

$6,309.08

in general payments reported to CMS, 2019-2025

40 companies · $1,404 in 2025

The $1,404 reported for 2025 was more than what 90% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).

See the full distribution for Gerontology (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,423.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $1,263.55 2022-2025 Ozempic, Wegovy, Rybelsus
Astrazeneca Pharmaceuticals LP $853.51 2022-2025 Farxiga, Airsupra, Breztri
Lilly USA, LLC $648.06 2022-2025 Mounjaro, Zepbound, Trulicity
Pfizer INC. $458.76 2021-2025
Glaxosmithkline, LLC. $401.64 2021-2025 Trelegy Ellipta, Arexvy, Shingrix
Abbvie INC. $350.20 2022-2025
Amgen INC. $303.48 2022-2025 Evenity, Otezla, Repatha
Boehringer Ingelheim Pharmaceuticals, INC. $253.81 2022-2025 Jardiance
Abbott Laboratories $185.62 2023-2025 Freestyle Libre 3
Bayer Healthcare Pharmaceuticals INC. $177.67 2022-2025
Merck Sharp & Dohme LLC $140.11 2022-2023 Belsomra
Nevro Corp. $133.55 2022
Teva Pharmaceuticals USA, INC. $111.87 2022-2024 Austedo Xr, Ajovy
Antares Pharma, INC. $104.87 2024-2025 Xyosted
Scilex Pharmaceuticals INC. $92.77 2023 Ztlido
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Janssen Pharmaceuticals, INC $88.15 2022-2023 Xarelto
Takeda Pharmaceuticals U.S.A., INC. $68.28 2022-2024 Trintellix
Vanda Pharmaceuticals INC. $64.72 2023 Fanapt, Hetlioz
Astellas Pharma US INC $62.90 2023-2025 Veozah
Sanofi-Aventis U.S. LLC $59.56 2022-2023
Currax Pharmaceuticals LLC $46.18 2022
Dexcom, INC. $45.14 2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $44.53 2022-2024 Xifaxan
Novartis Pharmaceuticals Corporation $41.35 2022
Sumitomo Pharma America, INC. $40.52 2024 Gemtesa
Boston Scientific Corporation $37.27 2025 Watchman Access System
Otsuka America Pharmaceutical, INC. $26.62 2024-2025 Rexulti
Biohaven Pharmaceutical Holding Company LTD. $23.70 2022
Phathom Pharmaceuticals, INC. $22.10 2025 Voquezna
Axsome Therapeutics, INC. $20.93 2023 Auvelity
Sanofi Pasteur INC. $15.50 2023
Seqirus USA INC $15.13 2025 Flucelvax, Fluad
Mayne Pharma Commercial LLC $14.29 2022
Medtronic, INC. $13.83 2022
Idorsia Pharmaceuticals US INC $13.45 2023 Quviviq
Eisai INC. $13.38 2022
Xeris Pharmaceuticals, INC. $13.28 2023 Gvoke Hypopen
Athena Bioscience, LLC $13.18 2024 Nexiclon Xr
Amarin Pharma, INC. $12.91 2022
Halozyme INC $12.71 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Justin Roberts

$6,309.08

in general payments reported 2019-2025

Years
2021-2025
Top company
Novo Nordisk INC
Context
The $1,404 reported for 2025 was more than what 90% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).

https://glasscript.com/doctor/10977068/justin-roberts

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.